Patents by Inventor Si-Young Cho

Si-Young Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10882882
    Abstract: The present specification relates to a novel compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, the compound being capable of being widely used in post fermented tea-related industries and various fields in which the compound may be used.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: January 5, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Yong-Deog Hong, Minsik Choi, Si Young Cho, Jeong-Kee Kim
  • Patent number: 10799551
    Abstract: Disclosed is to provide a composition derived from a natural material and which has an excellent effect of enhancing cognitive function and a method for preparing the same. The extract and composition according to one aspect of the present disclosure are derived from a natural material and thus are safe. It can prevent, ameliorate and treat cognitive decline. Therefore, it allows to improve the quality of life of the elderly population without concerns about side effects and promote development of the related industry.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: October 13, 2020
    Assignees: AMOREPACIFIC CORPORATION, INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
    Inventors: Hyungsu Kim, Ayoung Kim, Juewon Kim, Si Young Cho, Yong-Deog Hong, Seung Soo Chung, Suk Jin Ko, Ji Hyun Jeong, Ji Woong Ahn
  • Publication number: 20200222488
    Abstract: Disclosed is to provide a composition for skin-whitening or preventing or improving skin wrinkles, comprising a green tea extract which has modified amounts of ingredients. More specifically, the extract and composition according to one aspect of the present disclosure are derived from natural plants that cause less irritation to the skin and are eco-friendly, thus they are safe, and thereby the extract and composition can exhibit excellent effects of effectively inhibiting melanin production and tyrosinase activity and preventing or improving skin whitening, and can exhibit excellent effects of effectively inhibiting the expression of MMP-1 and preventing or improving skin wrinkles.
    Type: Application
    Filed: January 14, 2020
    Publication date: July 16, 2020
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Juewon KIM, Si Young CHO, Hyungsu KIM, Wonseok PARK, Joonho CHOI, Dong Hyun KIM, Jaewon YOU, Miyoung PARK
  • Patent number: 10550142
    Abstract: The present specification relates to a novel quercetin-based compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, the compound being capable of being widely used in post fermented tea-related industries and various fields in which the compound may be used.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: February 4, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Yong-Deog Hong, Minsik Choi, Si Young Cho, Jeong-Kee Kim
  • Patent number: 10483527
    Abstract: Provided is a cathode material for a rechargeable magnesium battery, represented by the chemical formula of Ag2SxSe1-x (0?x?1), a highly stable cathode material and a rechargeable magnesium battery including the same. The cathode material for a rechargeable magnesium battery has a higher discharge capacity and higher discharge voltage as compared to a typical commercially available cathode material, Chevrel phase, and shows excellent stability in an electrolyte for a rechargeable magnesium battery including chloride ions. In addition, after evaluating the cycle life of the cathode material, the cathode material shows an excellent discharge capacity per unit weight after 500 charge/discharge cycles, and thus is useful for a cathode material for a rechargeable magnesium battery.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: November 19, 2019
    Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Si Hyoung Oh, Byung Won Cho, Won Young Chang, Jung Hoon Ha, Boeun Lee, Hyo Ree Seo
  • Publication number: 20190284223
    Abstract: The present specification relates to a novel compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, the compound being capable of being widely used in post fermented tea-related industries and various fields in which the compound may be used.
    Type: Application
    Filed: October 12, 2017
    Publication date: September 19, 2019
    Inventors: Yong-Deog HONG, Minsik CHOI, Si Young CHO, Jeong-Kee KIM
  • Patent number: 10403886
    Abstract: Disclosed is an anode material for a sodium secondary battery. The anode material includes a tin fluoride-carbon composite composed of a tin fluoride and a carbonaceous material. The anode material can be used to improve the charge/discharge capacity, charge/discharge efficiency, and electrochemical activity of a sodium secondary battery. Also provided are a method for preparing the anode material and a sodium secondary battery including the anode material.
    Type: Grant
    Filed: January 2, 2017
    Date of Patent: September 3, 2019
    Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Kyung Yoon Chung, Ji-Hoon Lee, Ghulam Ali, Hun-Gi Jung, Wonchang Choi, Won Young Chang, Si Hyoung Oh, Byung Won Cho
  • Publication number: 20190248900
    Abstract: Disclosed are an antibody to human programmed cell death 1 (PD-1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, an isolated cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, and a composition for preventing or treating cancer containing the same. The novel antibody binding to PD-1 or an antigen-binding fragment thereof can bind to PD-1 and inhibit the activity of PD-1, thus being useful for the development of immunotherapeutic agents for various diseases associated with PD-1.
    Type: Application
    Filed: August 7, 2017
    Publication date: August 15, 2019
    Inventors: Jae Eun Park, Soo Young Kim, Hyun Mi Lee, Si Hyung Lee, Hyun Kyung Lee, Hye-Nan Kim, Jin Chul Youn, Bum-chan Park, Jung Chae Lim, Young-Gyu Cho, Young Woo Park
  • Publication number: 20190241601
    Abstract: The present specification relates to a novel quercetin-based compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, the compound being capable of being widely used in post fermented tea-related industries and various fields in which the compound may be used.
    Type: Application
    Filed: October 16, 2017
    Publication date: August 8, 2019
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Yong-Deog HONG, Minsik CHOI, Si Young CHO, Jeong-Kee KIM
  • Publication number: 20190091276
    Abstract: Disclosed is to provide a composition which is derived from a natural product and exhibits an excellent effect of protecting cells from oxidative stress and a method for preparing the same. The extract and composition according to one aspect of the present disclosure are derived from a natural product, thus are safe. It can prevent, ameliorate and treat oxidative stress and neuron damage. Therefore, it allows to improve the quality of life of the elderly population without concerns about side effects and promote development of the related industry.
    Type: Application
    Filed: August 23, 2018
    Publication date: March 28, 2019
    Inventors: Hyungsu KIM, Ayoung KIM, Juewon KIM, Si Young CHO, Yong-Deog HONG
  • Publication number: 20190091275
    Abstract: Disclosed is to provide a composition derived from a natural material and which has an excellent effect of enhancing cognitive function and a method for preparing the same. The extract and composition according to one aspect of the present disclosure are derived from a natural material and thus are safe. It can prevent, ameliorate and treat cognitive decline. Therefore, it allows to improve the quality of life of the elderly population without concerns about side effects and promote development of the related industry.
    Type: Application
    Filed: August 23, 2018
    Publication date: March 28, 2019
    Inventors: Hyungsu KIM, Ayoung KIM, Juewon KIM, Si Young CHO, Yong-Deog HONG, Seung Soo CHUNG, Suk Jin KO, Ji Hyun JEONG, Ji Woong AHN
  • Patent number: 10183048
    Abstract: Disclosed is a composition for promoting the activity of peroxisome proliferator-activated receptor-? (PPAR-?), which contains Artemisia vulgaris extracts or Artemisia capillaris extracts as active ingredients. The composition is effective in strengthening muscles, improving endurance and memory, and preventing and alleviating the symptoms of dementia or Parkinson's disease.
    Type: Grant
    Filed: November 25, 2010
    Date of Patent: January 22, 2019
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Si Young Cho, Pil Joon Park, Ji Hae Lee, Dae Bang Seo, Sang Jun Lee
  • Patent number: 10022351
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: July 17, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Patent number: 9999611
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: June 19, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Patent number: 9913823
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: October 18, 2012
    Date of Patent: March 13, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Patent number: 9839660
    Abstract: The present invention provides a composition comprising Astragali Radix extract as an active ingredient. The composition can increase body energy consumption and muscle metabolism. The present invention also relates to pharmaceutical and food compositions which include a composition comprising the Astragali Radix extract. The pharmaceutical and food compositions also increase body energy consumption and muscle metabolism.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: December 12, 2017
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Pil Joon Park, Si Young Cho, Dae Bang Seo, Sang Jun Lee
  • Patent number: 9795583
    Abstract: The present invention relates to a composition for preventing or treating heart disease, and more particularly, to a composition for preventing or treating heart disease, comprising (+)-syringaresinol. Specifically, (+)-syringaresinol as an active ingredient may exhibit excellent effect of preventing or improving heart disease by promoting SIRT1 expression and suppressing death of cardiomyocytes induced by reactive oxygen species. Accordingly, the composition according to the present disclosure may be used to prevent, improve or treat heart diseases including cardiovascular diseases.
    Type: Grant
    Filed: November 29, 2013
    Date of Patent: October 24, 2017
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Si Young Cho, Dae Bang Seo, Chan Woong Park, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20160263079
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Inventors: Byung Gyu KIM, Hyun Woo JEONG, Su Kyung KIM, Si Young CHO, Chan Woong PARK, Dae Bang SEO, Wan Gi KIM, Sang Jun LEE
  • Publication number: 20160263077
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Inventors: Byung Gyu KIM, Hyun Woo JEONG, Su Kyung KIM, Si Young CHO, Chan Woong PARK, Dae Bang SEO, Wan Gi KIM, Sang Jun LEE
  • Publication number: 20160263078
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Inventors: Byung Gyu KIM, Hyun Woo JEONG, Su Kyung KIM, Si Young CHO, Chan Woong PARK, Dae Bang SEO, Wan Gi KIM, Sang Jun LEE